NervGen Pharma Balance Sheet
NervGen Pharma's total assets for Q3 2025 were $9.39M, a decrease of -24.46% from the previous quarter. NGEN total liabilities were $11.50M for the fiscal quarter, a -12.23% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.